Using Lean to Deliver Commercial Gene Therapy Manufacturing

Tuesday, 5 November 2019 15:50 - 16:25

  • Adapting lean practices to fit a low throughput process, significantly improving process robustness
  • Thinking outside the box to increase capacity without increasing cleanroom footprint
  • Delivering the first US approved commercial gene therapy

Simon Simpkins, Vice President, Head of Manufacturing, Oxford BioMedica